About Trevena
Trevena is a company based in Philadelphia (United States) founded in 2007.. Trevena has raised $203 million across 10 funding rounds from investors including NIH, HHS and Forest Laboratories. The company has 35 employees as of December 31, 2022. Trevena operates in a competitive market with competitors including Flexion Therapeutics, Tonix Pharma, Cara Therapeutics, Eliem Therapeutics and Ethypharm, among others.
- Headquarter Philadelphia, United States
- Employees 35 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Trevena, Inc.
-
Annual Revenue
$3.07 M9800as on Dec 31, 2020
-
Net Profit
-
EBITDA
-
Total Equity Funding
$203 M (USD)
in 10 rounds
-
Latest Funding Round
$4 M (USD), Post-IPO
Dec 27, 2023
-
Investors
NIH
& 7 more
-
Employee Count
35
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Trevena
Trevena is a publicly listed company on the OTC with ticker symbol TRVN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Leadership Team
7 people
Key Team
3 people
Operations Team
1 people
Software Development Team
1 people
Unlock access to complete
Funding Insights of Trevena
Trevena has successfully raised a total of $203M across 10 strategic funding rounds. The most recent funding activity was a Post-IPO round of $4 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Post-IPO — $4.0M
-
First Round
First Round
(01 Mar 2008)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2023 | Amount | Post-IPO - Trevena | Valuation |
investors |
|
| May, 2013 | Amount | Series C - Trevena | Valuation | Polaris Partners , New Enterprise Associates |
|
| May, 2013 | Amount | Series C - Trevena | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Trevena
Trevena has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and Forest Laboratories. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US focused venture capital firm
|
Founded Year | Domain | Location | |
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on healthcare companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Trevena
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Trevena
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Trevena Comparisons
Competitors of Trevena
Trevena operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flexion Therapeutics, Tonix Pharma, Cara Therapeutics, Eliem Therapeutics and Ethypharm, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapies for the treatment of musculoskeletal disorders
|
|
| domain | founded_year | HQ Location |
Next-generation medicines for CNS and immunological disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for pain relief and inflammatory diseases
|
|
| domain | founded_year | HQ Location |
Develops antibody-based treatments for autoimmune and inflammatory disorders.
|
|
| domain | founded_year | HQ Location |
Therapies for pain and addiction treatment are developed.
|
|
| domain | founded_year | HQ Location |
Drug delivery systems for CNS disorders and pain are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Trevena
Frequently Asked Questions about Trevena
When was Trevena founded?
Trevena was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Where is Trevena located?
Trevena is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Is Trevena a funded company?
Trevena is a funded company, having raised a total of $203M across 10 funding rounds to date. The company's 1st funding round was a Series C of $60M, raised on Mar 01, 2008.
How many employees does Trevena have?
As of Dec 31, 2022, the latest employee count at Trevena is 35.
What is the annual revenue of Trevena?
Annual revenue of Trevena is $3.07M as on Dec 31, 2020.
What does Trevena do?
Trevena is a developer of GPCR ligand technology-based therapeutics for cardiovascular diseases and pain. It has three programs in development: TRV027, currently in Phase 2 clinical testing for the treatment of acute heart failure; TRV130, currently completing phase 1 testing for the intravenous treatment of postoperative pain; and TRV734, currently in pre-clinical testing for oral treatment of acute and chronic pain. In addition, Trevena has built an early-stage portfolio of drug discovery programs currently in lead optimization.
Who are the top competitors of Trevena?
Trevena's top competitors include Flexion Therapeutics, Tonix Pharma and Cara Therapeutics.
Is Trevena publicly traded?
Yes, Trevena is publicly traded on OTC under the ticker symbol TRVN.
Who are Trevena's investors?
Trevena has 8 investors. Key investors include NIH, HHS, Forest Laboratories, Polaris Partners, and NEA.
What is Trevena's ticker symbol?
The ticker symbol of Trevena is TRVN on OTC.